Showing results 69 to 88 of 174
< previous
next >
Issue Date | Title | Author(s) |
2013 | Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Extranodal Staging of Non-Hodgkin Lymphoma and Hodgkin Disease | Ömür, Özgür; Baran, Yusuf ; Oral, Aylin; Ceylan, Yeşim |
2023 | Foreword | Baran, Y. |
2010 | Gene expression profiles in resveratrol applied acute promyelocytic leukemia cells | Baran, Yusuf ; Çakır, Zeynep; Can, Geylani; Saydam, Güray; Şahin, Fahri |
2010 | Gene expression profiles in resveratrol-induced cell death in acute promyelocytic leukemia cells | Çakır, Zeynep; Can, Geylani; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |
2015 | A genome-wide analyses of differentially expressed genes and related networks affected by fisetin and hesperetin in chronic myeloid leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
2013 | Gossypol interferes with both type I and Type II topoisomerase activities without generating strand breaks | Şenarısoy, Müge; Cantürk, Pakize; Zencir, Sevil; Baran, Yusuf ; Topçu, Zeki |
2013 | Granulocytic sarcoma: a systematic review | Yılmaz, Asu Fergün; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |
2023 | HER2-specific peptide (LTVSPWY) and antibody (herceptin) targeted core cross-linked micelles for breast cancer: A Comparative study | Bayram, N.N.; Ulu, G.T.; Abdulhadi, N.A.; Gürdap, S.; İşoğlu, İ.A.; Baran, Yusuf ; İşoğlu, S.D. |
2022 | HER2-Targeted, Degradable Core Cross-Linked Micelles for Specific and Dual pH-Sensitive DOX Release | Bayram, N.N.; Ulu, G.T.; Topuzoğulları, M.; Baran, Y. ; Dinçer, İşoğlu, S. |
28-Oct-2021 | HER2-targeted, degradable core cross-linked micelles for specific and dual pH-sensitive DOX release | Bayram, Nazende Nur; Ulu, Gizem Tuğçe ; Topuzoğulları, Murat; Baran, Yusuf ; Dinçer İşoğlu, Sevil |
2018 | Hesperidin promotes programmed cell death by downregulation of nongenomic estrogen receptor signalling pathway in endometrial cancer cells | Cincin, Zeynep Birsu; Kıran, Bayram; Baran, Yusuf ; Çakmakoğlu, Bedia |
2011 | Hormona dirençli prostat kanseri hücrelerinde dosetaksel ve seramidin induklediği apoptozisde seramid genlerinin ve ürünlerinin eksprersyon düzeylerinin araştırılması | Baran, Yusuf |
Mar-2011 | Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells | Can, Geylani; Ekiz, Hüseyin Atakan ; Baran, Yusuf |
2009 | Imatinib induces autophagy through increasing the expression levels of Beclin-1 and ATG-5 genes in both parental sensitive and imatinib-resistant K562 cells | Baran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan ; Genç, S. G. |
6-Dec-2011 | Imatinib-induced apoptosis: A possible link to topoisomerase enzyme inhibition | Baran, Yusuf ; Zencir, Sevil; Çakır, Zeynep; Öztürk, Esra; Topçu, Zeki |
2013 | Immunologically detection of BCR/ABL fusion protein with flow cytometry in K562 chronic myeloid leukemia cells and comparison with RT-PCR results | Kozanoğlu, İlknur; Aygün, B.; Boğa, I.; Cansun, C.; Üstündağ, N.; Baran, Yusuf ; Özdoğu, Hakan |
2011 | The importance of protein profiling in the diagnosis and treatment of hematologic malignancies | Şanlı Mohamed, Gülşah ; Turan, Taylan; Ekiz, Hüseyin Atakan ; Baran, Yusuf |
2010 | Increasing chemosensitivity of chronic myeloid leukemia cells to dasatinib by targeting bioactive sphingolipids | Gencer, Emel Başak |
2009 | Increasing de novo synthesis of ceramides increased nilotinib induced apoptosis in human MEG-01 chronic megacaryoblastic cells | Baran, Yusuf ; Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit |
2009 | Increasing intracellular generation or accumulation of ceramides increased cytotoxic effects of resveratrol in human k562 chronic myeloid leukemia cells | Kartal Yandım, Melis; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |